Ginkgo Bioworks Holdings, Inc. (DNA) Q2 2025 Earnings Call Transcript

2025-08-08 03:16:04 ET

Ginkgo Bioworks Holdings, Inc. (DNA)

Q2 2025 Earnings Conference Call

August 07, 2025, 05:30 PM ET

Company Participants

Daniel Waid Marshall - Senior Manager of Communications and Ownership

Jason Kelly - Founder, CEO & Director

Steven P. Coen - Chief Accounting Officer & CFO

Presentation

Daniel Waid Marshall

Good evening. I'm Daniel Marshall, Senior Manager of Communications and Ownership. I'm joined by Jason Kelly, our Co-Founder and CEO; and our new CFO, Steve Coen. Thanks, as always, for joining us. We're looking forward to updating you on our progress.

As a reminder, during the presentation today, we'll be making forward-looking statements, which involve risks and uncertainties. Please refer to our filings with the SEC to learn more about these risks and uncertainties, including our most recent 10-K. Today, in addition to updating you on the quarter results, we're going to provide updates on our path towards adjusted EBITDA breakeven and dive deeper into the new deals and launches in Ginkgo's Tools businesses, which continue to establish themselves as critical tools in AI-powered bioengineering. As usual, we'll end with a Q&A session, and I'll take questions from analysts, investors and the public. You can submit those questions to us in advance via #Ginkgoresults or e-mail investors@ginkgobioworks.com. All right. Over to you, Jason....

Read the full article on Seeking Alpha

For further details see: